After Pfizer, the National Pharmaceutical Regulatory Agency (NPRA) is now looking into Sinovac's application for the vaccine to be used on adolescents in the country.

According to the Health Ministry, the Beijing-based pharmaceutical company has submitted its dossier recently to seek the agency's approval.

"Yes, Sinovac has submitted. They (NPRA) are now...